Semdor Pharma adds Global Pharmaceutical Executive Rolf Hoffmann to its Board of Directors

30-year pharma veteran Rolf Hoffmann, previously senior world govt at Amgen and Eli Lilly, joins Semdor Pharma as investor and industrial skilled.

Cologne, March 29th, 2021 — Semdor Pharma Crew introduced these days that it has added Rolf Hoffmann, a seasoned world pharma govt and consultant, to its Board of Administrators, in addition to an investor within the corporate. Mr. Hoffmann prior to now served at Amgen as Senior Vice President of Business Operations (US) and SVP of Global and Europe, the place he fascinated with operations, scaling and organizational construction. Mr. Hoffmann began his pharmaceutical profession at Eli Lilly as a gross sales consultant, progressing briefly to senior positions together with President of Latin The us Operations and Normal Supervisor in Germany. Since parting from Amgen in 2016, Mr. Hoffmann has served on a large number of forums associated with the pharmaceutical and biotechnical sector, together with STADA (Germany’s biggest impartial Generics/OTC endeavor), Danish Genmab (Europe’s biggest Biotech corporate) and EUSA Pharma (a Eu uniqueness pharmaceutical corporate fascinated with oncology and oncology supportive care), amongst others.

“Semdor Pharma attracted me as a result of their transparent venture of creating a next-generation Eu uniqueness pharmaceutical corporate centered at the large drawback of bodily and psychological ache and struggling. No different situation takes this sort of massive emotional and monetary toll on Eu society and Semdor’s explanation why for being is apparent. No different Eu platform is in a position to be offering the marketplace this sort of wide array of life-enhancing drugs, from conventional ache medicines to the exploding space of scientific hashish merchandise. Semdor has a generational alternative and I’m excited to impart my enjoy scaling pharma companies as a Board Director and investor”, mentioned Rolf Hoffmann.

“I’m happy with the laborious paintings of each and every member of the Semdor workforce and our venture stays transparent: providing Eu sufferers probably the most leading edge, best high quality ache medication and comparable merchandise, whether or not conventional ache remedies or scientific hashish. We’re in a more potent place than ever to construct Semdor’s platform, together with the Cannamedical emblem, as a pacesetter within the Eu scientific hashish business” mentioned David Henn, CEO of Semdor “With over 30 yr of enjoy serving to expand pharma platforms in Europe, North The us and Latin The us, Rolf is an ideal have compatibility as an investor and Board Director.”

About Semdor Pharma Crew
The formation of Semdor Pharma Crew in January 2021 established one in every of Europe’s main pharmaceutical teams specialised in narcotics and scientific hashish. Semdor Pharma Crew used to be shaped during the merger of the German narcotics products and services marketplace chief PS Crew (together with subsidiaries PS Pharma Products and services, PB Pharma and PS Advertising and marketing & Outsourcing) and Cannamedical Pharma, which is the main impartial scientific hashish emblem in Germany. Semdor provides Eu wholesalers, providers and pharmacies the broadest array of narcotic drugs (each artificial and herbal) and offers key narcotic and scientific hashish gamers the broadest choice of market-leading product uploading, dealing with, packaging and system products and services. Semdor Pharma generates gross annual gross sales of greater than 60 million euros and employs 180 workforce individuals in Cologne and Meerbusch, Germany.

Press Family members
Leonie Weskott
E-Mail: presse@semdor-group.com
Telephone: +49 (zero) 221 9999 6151


Leave a Reply

Your email address will not be published. Required fields are marked *